Sagimet Biosciences Inc. Series A Common Stock SGMT
$9.92
-4.89%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 1 Sell)
- Average Price Target
- $26.46
- Implied Upside
- +166.8%
- Price Target Range
- $7.00 – $56.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-05 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $29 |
| 2026-10-02 | GuggenheimSeamus Fernandez |
Maintains | Buy | $25 → $26 |
| 2026-10-01 | OppenheimerJay Olson |
Maintains | Outperform | $33 → $38 |
| 2026-10-01 | CitizensJonathan Wolleben |
Maintains | Market outperform | $29 → $27 |
| 2026-09-24 | Goldman SachsAndrea Newkirk |
Reinstates | Sell | $7 |
| 2026-09-09 | BarclaysEliana Merle |
Upgrades | Equal-weight → Overweight | $8 → $18 |
| 2026-09-09 | Cantor FitzgeraldYanni Souroutzidis |
Initiates coverage on | Overweight | $11 |
| 2026-08-25 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $29 |
| 2026-08-14 | CitizensJonathan Wolleben |
Maintains | Market outperform | $12 → $29 |
| 2026-08-12 | Canaccord GenuityEdward Nash |
Maintains | Buy | $49 → $56 |
| 2026-05-19 | CitizensJonathan Wolleben |
Maintains | Market outperform | $35 → $12 |
| 2026-05-04 | Canaccord GenuityEdward Nash |
Maintains | Buy | $28 → $49 |
| 2026-04-29 | GuggenheimSeamus Fernandez |
Maintains | Buy | $27 → $25 |
| 2026-03-11 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $29 |
| 2026-02-03 | GuggenheimSeamus Fernandez |
Initiates coverage on | Buy | $27 |
| 2026-02-03 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $29 |
| 2026-01-28 | BarclaysEliana Merle |
Initiates coverage on | Equal-weight | $8 |
| 2025-11-14 | CitizensJonathan Wolleben |
Maintains | Market outperform | $33 → $35 |
| 2025-10-22 | Clear StreetKaveri Pohlman |
Initiates coverage on | Buy | $29 |
| 2025-10-02 | Canaccord GenuityEdward Nash |
Maintains | Buy | $28 |
| 2025-08-11 | WedbushYun Zhong |
Initiates coverage on | Outperform | $28 |
| 2025-08-07 | HC Wainwright & Co.Brandon Folkes |
Assumes | Buy | $29 |
| 2025-07-24 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $28 |
| 2025-06-06 | Jones TradingDebanjana Chatterjee |
Maintains | Buy | $15 → $27 |
| 2025-03-13 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $32 |
| 2025-03-11 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $32 |
| 2025-01-27 | Jones TradingDebanjana Chatterjee |
Initiates coverage on | Buy | $42 |
| 2024-12-06 | OppenheimerJay Olson |
Initiates coverage on | Outperform | $30 |
| 2024-11-15 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $32 |
| 2024-11-12 | UBSEliana Merle |
Initiates coverage on | Buy | $12 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $9.92
- Market Cap
- $739.58 million
- 52-Week Range
- $4.50 – $11.45
- Average Volume
- 1.48 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.